<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="[OANC]/data/written_2/technical/biomed/1471-2350-2-8.anc" start="11136" end="11142" sStart="11018" offset="118" sid="r11.strong.j.0277" wn="1" wnkey="strong%3:00:00::" annotator="vebatchelder" text="Association between APOE gene polymorphism and diabetic nephropathy may be weak or moderate, but not strong." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2350-2-8.anc" start="119" end="125" sStart="null" offset="76" sid="r11.strong.j.0101" wn="1" wnkey="strong%3:00:00::" annotator="anfahmy" text="Familial and epidemiological studies have indicated that there is a strong genetic component in the aetiology of diabetic nephropathy in Type I diabetes patients [ 1, 2]." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-2350-2-8.anc" start="6976" end="6981" sStart="null" offset="0" sid="null" wn="4" wnkey="show%2:39:00::" annotator="carichter" text="The distribution of the APOE genotypes is &lt;b&gt;shown&lt;/b&gt; in Table 2. There was no significant difference in APOE genotype and allele frequency between nephropathic and normoalbuminuric diabetic patients." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2350-2-8.anc" start="2606" end="2612" sStart="null" offset="42" sid="r9.level.n.0570" wn="1" wnkey="level%1:07:00::" annotator="anfahmy" text="At entry the patients had HbAlc levels of 5.7 to 16." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2350-2-8.anc" start="733" end="739" sStart="null" offset="136" sid="r10.common.j.0166" wn="3" wnkey="common%5:00:00:shared:00" annotator="anfahmy" text="There are three common alleles, E2, E3, and E4, which code for three major isoforms, resulting in six common genotypes [ 3, 4]." />
  </sentences>
</list>